Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice (Q83880274)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 April 2011

Language	Label	Description	Also known as
English	Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice	scientific article published on 15 April 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lactococcus lactis

object named as

Lactococcus lactis

1 reference

based on heuristic

inferred from title

author name string

Hou Jing

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lu Yong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Liu Haiyan

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Ma Yanjun

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Xing Yun

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Zhang Yu

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Li Taiming

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Cao Rongyue

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jin Liang

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Wu Jie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Zong Li

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Liu Jingjing

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

15 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4102-4109

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Role of Inflammation in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Role of heat shock proteins in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Perspectives on mucosal vaccines: is mucosal tolerance a barrier?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

The Mycobacterium leprae hsp65 displays proteolytic activity. Mutagenesis studies indicate that the M. leprae hsp65 proteolytic activity is catalytically related to the HslVU protease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Lactococcus lactis as a cell factory for delivery of therapeutic proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Production of human papillomavirus type 16 E7 protein in Lactococcus lactis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Cloning of usp45, a gene encoding a secreted protein from Lactococcus lactis subsp. lactis MG1363.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Current issues in the treatment of human diseases by mucosal tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Survival of lactococci during passage through mouse digestive tract.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunisations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

Genetic transformation of intact Lactococcus lactis subsp. lactis by high-voltage electroporation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.105

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.03.105

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21497632%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83880274&oldid=2006024024"